Hi, Spideyboy. I have one more question for you. I wonder if you ever compared the PRX-102 with the future possible competitors Lucerastat and Venglustat. I myself did a small DD read this article https://fabrydiseasenews.com/2020/02/04/ert-vs-srt-which-would-be-more-effective-for-fabry something else and came to the conclusion that they still need 3-5 years to get to the market. Apparently these medicines will need to go through face to face study with best ERT(hopefully PRX-102) etc. If you have something to share on this subject I would appreciate it.
Market Data 
Markets 
AI
